Target intelligence / Profile preview

PRELI domain containing 3B pseudogene 4 (PRELID3BP4)

Target
PRELID3BP4
Molecular classification
Other (processed pseudogene)
01

Overview

PRELI domain containing 3B pseudogene 4 (PRELID3BP4) is a processed pseudogene, meaning it originated from the retrotransposition of a parent gene's mRNA and is generally considered non-functional at the protein level[4][7]. Like many processed pseudogenes, it lacks introns and is usually distinguished from active genes by mutations that prevent translation into a functional protein. While the role of some pseudogenes has evolved to include regulation of their parent gene or of gene expression networks via noncoding RNAs, there is currently no evidence that PRELID3BP4 encodes a functional protein or is a therapeutic target[1][5][7]. Scientific databases such as Ensembl (ENSG00000251163) and NCBI Gene (ID: 100420275) classify PRELID3BP4 as a pseudogene with no established function[2][4].\n\nThis entry refers to a pseudogene, not a true gene encoding a functional protein, receptor, enzyme, transporter, or other molecule typical of therapeutic targeting. Pseudogenes may be transcribed and can have regulatory roles, but PRELID3BP4 specifically does not have known roles in disease, drug response, or biomarker function[1][4][5][7].\n\nIf your focus is on therapeutic targets, PRELID3BP4 should *not* be included as a target unless future research identifies a novel function.

Other names
PRELI domain containing 3B pseudogene 4PRELID3BP4slowmo homolog 2 pseudogene
02

Biological functions

Other (No established canonical protein-coding function; as a pseudogene, it may have regulatory functions at the RNA level, such as acting as a competitive endogenous RNA or through antisense mechanisms, but there is no direct evidence specific to PRELID3BP4[1][7].)
03

Disease associations

Other (No direct disease association or causation documented for PRELID3BP4; but related pseudogenes sometimes have regulatory roles in disease contexts[1][7].)

Beyond the preview

Go deeper on PRELI domain containing 3B pseudogene 4 (PRELID3BP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRELI domain containing 3B pseudogene 4 (PRELID3BP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call